Clark Zhang Ph.D.

Clark Zhang is an associate providing strategic intellectual property counsel to clients developing cutting edge innovations in both the life sciences and high-tech industries. Clark’s technical expertise involve big data, machine learning, digital health, computational biology, and bioinformatics. Today, Clark combines his prior technical training in the biomedical sciences as well as patent expertise in the high-tech industries to advise clients situated at the intersection of software and life sciences.

Prior to joining Goodwin, Dr. Zhang was a patent agent at Fenwick & West LLP. Prior to that, Dr. Zhang pursued his doctoral thesis in the Center for Nanomedicine at Johns Hopkins University, where he focused on engineering drug and gene nanoparticles for delivery and treatment of neurological diseases.

• “The Evolving Standard for Patent Claim Definiteness,” Daily Journal, February 2018.
• “NAFTA Renegotiation of Intellectual Property Provisions,” Daily Journal, April 2018.
• “Convection Enhanced Delivery of Cisplatin-Loaded Brain Penetrating Nanoparticles Cures Malignant Glioma in Rats,” Journal of Controlled Release, October 2017, 263, 112-119.
• “Strategies to Achieve Maximal Nanotherapeutic Distribution in the Brain,” Journal of Controlled Release, December 2017, 267, 232-239.